Pfizer Withdraws Emergency Use Application for COVID-19 Vaccine in India

New Delhi: Pharma giant Pfizer announced that it has withdrawn the emergency use authorisation application for its coronavirus vaccine in India.

“In pursuance of the Emergency Use Authorisation of its COVID-19 vaccine, Pfizer participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3. Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” Pfizer said in a statement today.

Pfizer was the first pharmaceutical company to seek EUA from Drugs Controller General of India (DCGI) after its vaccine was approved in the UK and Bahrain.

The company said that it will continue to engage with the authority and submits its approval request again with more information in the near future.

It said that it remains committed to make its coronavirus vaccine available for use by the Indian government. It said it will pursue the required process to gain emergency use approval by the government.